DK2969005T3 - Attenuerede influenzavira og -vacciner - Google Patents

Attenuerede influenzavira og -vacciner Download PDF

Info

Publication number
DK2969005T3
DK2969005T3 DK14763039.6T DK14763039T DK2969005T3 DK 2969005 T3 DK2969005 T3 DK 2969005T3 DK 14763039 T DK14763039 T DK 14763039T DK 2969005 T3 DK2969005 T3 DK 2969005T3
Authority
DK
Denmark
Prior art keywords
influenzavira
vaccines
attenuated
attenuated influenzavira
Prior art date
Application number
DK14763039.6T
Other languages
English (en)
Inventor
Steffen Mueller
Eckard Wimmer
Steven Skiena
Chen Yang
Bruce Futcher
Original Assignee
The Resaerch Foundation For The State Univ Of New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Resaerch Foundation For The State Univ Of New York filed Critical The Resaerch Foundation For The State Univ Of New York
Application granted granted Critical
Publication of DK2969005T3 publication Critical patent/DK2969005T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16061—Methods of inactivation or attenuation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16161—Methods of inactivation or attenuation
    • C12N2760/16162—Methods of inactivation or attenuation by genetic engineering

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK14763039.6T 2013-03-15 2014-03-15 Attenuerede influenzavira og -vacciner DK2969005T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361794617P 2013-03-15 2013-03-15
PCT/US2014/030027 WO2014145290A1 (en) 2013-03-15 2014-03-15 Attenuated influenza viruses and vaccines

Publications (1)

Publication Number Publication Date
DK2969005T3 true DK2969005T3 (da) 2020-01-20

Family

ID=51537937

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14763039.6T DK2969005T3 (da) 2013-03-15 2014-03-15 Attenuerede influenzavira og -vacciner

Country Status (7)

Country Link
US (3) US10316294B2 (da)
EP (2) EP3653701A1 (da)
CA (1) CA2906823C (da)
DK (1) DK2969005T3 (da)
HR (1) HRP20200012T1 (da)
PL (1) PL2969005T3 (da)
WO (1) WO2014145290A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3653701A1 (en) * 2013-03-15 2020-05-20 The Research Foundation for The State University of New York Attenuated influenza viruses and vaccines
TWI801328B (zh) * 2015-07-17 2023-05-11 香港商港大科橋有限公司 包括咪喹莫特的局部調配物之用途
AR111770A1 (es) 2017-05-05 2019-08-21 Elanco Us Inc Vacuna para enfermedad respiratoria bovina
US12178869B2 (en) 2017-12-22 2024-12-31 Codagenix Inc. Recombinant virus with codon-pair deoptimized region and uses thereof for the treatment of cancer
RU2020132280A (ru) 2018-03-08 2022-04-11 Кодадженикс Инк. Аттенуированные флавивирусы
CN112574958B (zh) * 2019-09-28 2022-09-09 普莱柯生物工程股份有限公司 一株h9亚型禽流感病毒分离株及其应用
CN112964683B (zh) * 2021-02-08 2022-06-17 山西医科大学 叶酸修饰氮掺杂石墨烯量子点/银纳米荧光探针的制备方法和应用
WO2023102520A1 (en) * 2021-12-02 2023-06-08 Codagenix Inc. Parenterally administrable influenza vaccine and uses thereof
CN114264821B (zh) * 2021-12-24 2024-04-26 江南大学 检测新型冠状病毒中和抗体的试剂盒及其制备方法与应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1766059B1 (en) 2004-05-25 2012-07-11 MedImmune Vaccines, Inc. Influenza hemagglutinin and neuraminidase variants
CA2587084C (en) 2004-10-08 2019-07-16 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Modulation of replicative fitness by using less frequently used synonym ous codons
CA2598884A1 (en) 2005-02-24 2006-10-05 University Of Massachusetts Influenza nucleic acids, polypeptides, and uses thereof
EP1996610A1 (en) 2006-03-15 2008-12-03 Intervet International BV Recombinant newcastle disease virus expressing h5 hemagglutinin of avian influenza virus
WO2007130327A2 (en) 2006-05-01 2007-11-15 Technovax, Inc. Influenza virus-like particle (vlp) compositions
AU2007286161B2 (en) 2006-08-09 2013-05-02 Medimmune, Llc Influenza hemagglutinin and neuraminidase variants
US9476032B2 (en) * 2007-03-30 2016-10-25 The Research Foundation For The State University Of New York Attenuated viruses useful for vaccines
TW201125984A (en) 2009-10-09 2011-08-01 Univ New York State Res Found Attenuated influenza viruses and vaccines
US8298820B2 (en) 2010-01-26 2012-10-30 The Trustees Of The University Of Pennsylvania Influenza nucleic acid molecules and vaccines made therefrom
US20110184160A1 (en) 2010-01-26 2011-07-28 Weiner David B Nucleic acid molecule encoding consensus influenza a hemagglutinin h1
WO2012089231A1 (en) 2010-12-30 2012-07-05 Okairòs Ag Paramyxovirus vaccines
WO2013130132A1 (en) 2011-10-07 2013-09-06 Medimmune, Llc Influenza hemagglutinin variants
HRP20230694T1 (hr) 2013-02-08 2023-10-13 The U.S.A. As Represented By The Secretary, Department Of Health And Human Services Smanjenje ljudskog respiratornog sincicijskog virusa prema ljestvici genoma deoptimizacijom kodon-para
EP3653701A1 (en) * 2013-03-15 2020-05-20 The Research Foundation for The State University of New York Attenuated influenza viruses and vaccines

Also Published As

Publication number Publication date
EP2969005A1 (en) 2016-01-20
US20160024477A1 (en) 2016-01-28
WO2014145290A1 (en) 2014-09-18
CA2906823C (en) 2023-01-03
EP3653701A1 (en) 2020-05-20
CA2906823A1 (en) 2014-09-18
US20240228978A1 (en) 2024-07-11
US11549101B2 (en) 2023-01-10
US20210009962A1 (en) 2021-01-14
PL2969005T3 (pl) 2020-04-30
EP2969005B1 (en) 2019-10-16
EP2969005A4 (en) 2016-11-30
US10316294B2 (en) 2019-06-11
HRP20200012T1 (hr) 2020-03-20
HK1220656A1 (en) 2017-05-12

Similar Documents

Publication Publication Date Title
NO2023026I1 (no) Dengue tetravalent vaccine
DK3536797T3 (da) Forhøjet transgenudtrykkelse og -forarbejdning
DK4056212T3 (da) Autoinjektor
DK3043784T3 (da) Arylethere og anvendelser deraf
DK3003039T3 (da) Methyl/fluor-pyridinyl-metoxy-substituerede pyridinon-pyridinyl-forbindelser og fluor-pyrimidinyl-metoxy-substituerede pyridinon-pyridinyl-forbindelser
UA29910S (uk) Блендер
LT2970303T (lt) Pakeistieji ksantinai ir jų panaudojimo metodai
DK2962100T3 (da) Tuberkulosebiomarkører og anvendelser deraf
EP2958994A4 (en) Vaccine composition
HRP20181376T1 (hr) Poboljšana cjepiva protiv poksvirusa
BR112016011147A2 (pt) autoinjetor
PT3055308T (pt) Resumo
DK2969005T3 (da) Attenuerede influenzavira og -vacciner
DK3029038T3 (da) Tetrazolinonforbindelse og anvendelse deraf
DK3068505T3 (da) Spillesystem og -fremgangsmåde
UA29750S (uk) Інгалятор
IL244354B (en) Influenza vaccine and therapy
HUE049248T2 (hu) Inhalátor
HUE053417T2 (hu) Inhalátor
EP3041028A4 (en) LAMINATE AND APPLICATION THEREOF
PT3035887T (pt) Inalador
LT3060660T (lt) Rekombinantiniai glikoproteinai ir jų naudojimas
EP3051144A4 (en) COMPRESSORS AND CHARGERS
DK2958935T3 (da) Vaccine
BR112015024661A2 (pt) silo e silo elevado